Question 1

What are the potential benefits of combining bevacizumab and tocotrienol for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer clinical trial (NCT04175470). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer clinical trial (NCT04175470). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer clinical trial (NCT04175470). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any other treatment options I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer clinical trial (NCT04175470). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this trial affect my daily life and routine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer clinical trial (NCT04175470). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I show an increase in HOXA9 meth-ctDNA after the first cycle?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer clinical trial (NCT04175470). Contact the study team or your healthcare provider for specific answers.

What this study is about